Cargando...
Mitochondrial mutations and metabolic adaptation in pancreatic cancer
BACKGROUND: Pancreatic cancer has a five-year survival rate of ~8%, with characteristic molecular heterogeneity and restricted treatment options. Targeting metabolism has emerged as a potentially effective therapeutic strategy for cancers such as pancreatic cancer, which are driven by genetic altera...
Gardado en:
| Publicado en: | Cancer Metab |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5282905/ https://ncbi.nlm.nih.gov/pubmed/28163917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-017-0164-1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|